Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary FibrosisNot Yet Recruiting
NCT07441408Phase 3Updated Aug 14, 2026
Sponsor: Bristol-Myers Squibb
Pulmonary Fibrosis
United States, Argentina, Australia, Belgium, Brazil +22 more
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyRecruiting
NCT07052903Phase 3Updated Aug 14, 2026
Sponsor: Alnylam Pharmaceuticals
Transthyretin Amyloidosis With Cardiomyopathy
United States, Argentina, Australia, Austria, Belgium +30 more
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Active Not Recruiting
NCT05878769Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Austria, Belgium +35 more
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)Recruiting
NCT07419295Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Argentina, Australia, Belgium, Brazil +11 more
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Active Not Recruiting
NCT04736706Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Brazil, Canada, Chile +30 more
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With PolyneuropathyRecruiting
NCT07223203Phase 3Updated Aug 14, 2026
Sponsor: Alnylam Pharmaceuticals
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy · hATTR-PN
United States, Australia, Brazil, Canada, Cyprus +12 more
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting
NCT06966700Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruiting
NCT07108283Phase 2Updated Aug 14, 2026
Sponsor: Takeda
Nonsegmental Vitiligo
United States, Canada, China, France, Italy +4 more
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Recruiting
NCT06629779Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresRecruiting
NCT05077904Phase 3Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Stereotypical Prolonged Seizures
United States, Australia, Bulgaria, China, Czechia +8 more
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral TherapyRecruiting
NCT07682961Phase 3Updated Aug 14, 2026
Sponsor: Gilead Sciences
HIV Infections
United States, Australia, Japan
A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruiting
NCT07392450Phase 2Updated Aug 14, 2026
Sponsor: Takeda
Acute Ischemic Stroke
United States, Belgium, Brazil, China, France +5 more
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruiting
NCT07013474Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Recruiting
NCT06152575Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Belgium, Brazil +22 more
A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 DiabetesNot Yet Recruiting
NCT07765511Phase 1Updated Aug 14, 2026
Sponsor: Eli Lilly and Company
Obesity · Overweight
Japan
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Recruiting
NCT06824467Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
United States, Argentina, Australia, Austria, Belgium +24 more
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruiting
NCT07555938Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Multiple Myeloma
United States, Canada, Germany, Greece, Israel +6 more
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in ChinaCompleted
NCT06421740N/AUpdated Aug 14, 2026
Sponsor: AbbVie
Atopic Dermatitis
China
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruiting
NCT07155174Phase 2Updated Aug 14, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Belgium, China, Germany, Israel +8 more
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting
NCT04649242Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Pediatric Migraine
United States, Canada, China, Japan, Mexico +4 more
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesRecruiting
NCT07351045Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Obesity or Overweight
United States, Argentina, Australia, Belgium, Brazil +15 more
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BCompleted
NCT03938792Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Bulgaria, Canada, China, Croatia +15 more
Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative ColitisRecruiting
NCT07136116N/AUpdated Aug 14, 2026
Sponsor: AbbVie
Ulcerative Colitis
Japan
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 DiabetesCompleted
NCT07271251Phase 3Updated Aug 13, 2026
Sponsor: Novo Nordisk A/S
Type 2 Diabetes
Japan
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemRecruiting
NCT07118358NAUpdated Aug 13, 2026
Sponsor: Biotronik, Inc.
Leadless Pacemaker · Bradycardia · AV Block · Cardiac Rhythm Disorder
United States, Australia, Austria, Belgium, France +3 more

Previous page Next page